Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, open-label, comparative, multi-center trial to evaluate the effects on hemostasis, lipids, carbohydrate metabolism, and on adrenal and thyroid function of a monophasic COC[combined oral contraceptive] containing 2.5 mg NOMAC [nomegestrol] and 1.5 mg E2 [estradiol] compared to a monophasic COC containing 150 microg LNG[levonorgestrel] and 30 microg EE [ethinyl estradiol]

Trial Profile

A randomized, open-label, comparative, multi-center trial to evaluate the effects on hemostasis, lipids, carbohydrate metabolism, and on adrenal and thyroid function of a monophasic COC[combined oral contraceptive] containing 2.5 mg NOMAC [nomegestrol] and 1.5 mg E2 [estradiol] compared to a monophasic COC containing 150 microg LNG[levonorgestrel] and 30 microg EE [ethinyl estradiol]

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 11 Feb 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Estradiol/nomegestrol (Primary) ; Ethinylestradiol/levonorgestrel
  • Indications Pregnancy
  • Focus Pharmacodynamics
  • Sponsors Organon
  • Most Recent Events

    • 01 Dec 2011 Results published in the European Journal of Contraception and Reproductive Health Care.
    • 09 Oct 2009 Actual patient number (121) added as reported by ClinicalTrials.gov.
    • 30 May 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top